Navigation Links
Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
Date:10/24/2011

PINE BROOK, N.J., Oct. 24, 2011 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company focused on the development of antibody therapeutics, announced today that it is initiating a new clinical study to further demonstrate the safety of Anthim (ETI-204), the company's anti-toxin in late-stage development for prevention of disease and death from exposure to inhaled anthrax. The company also announced it has successfully manufactured Anthim at commercial scale. Anthim is an anti-toxin that significantly increases survival in anthrax-infected animals and is a promising candidate for the treatment of anthrax infection in people following a biowarfare attack.

(Logo: http://photos.prnewswire.com/prnh/20090420/NY01624LOGO)

The double blind, placebo-controlled dose-escalating study will include a total of 108 healthy human subjects and is designed to collect additional safety and pharmacokinetic (PK) data on Anthim.

"Our development timeline for Anthim is right on track, and this additional safety and PK data will further prove Anthim's utility as a strong candidate for addition to the Strategic National Stockpile," said Elizabeth Posillico, PhD, President and Chief Executive Officer of Elusys. "Anthim is demonstrating the potential to deliver significant therapeutic benefit to Americans infected with anthrax in a bioterrorism emergency."

Dr. Posillico will be presenting an update on Anthim's development program at the 10th Annual BIO Investor Forum in San Francisco on October 26.

"We have successfully manufactured Anthim at commercial scale, and look forward to finalizing our commercial production process to ensure the large-scale capacity needed to deliver high quality, consistent quantities of Anthim for the long term," added James Porter, Vice President of Development and Manufacturing at Elusys.

Anthrax is a life-threatening infectious disease caused by the bacterium Bacillus anthracis and remains one
'/>"/>

SOURCE Elusys Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection
2. Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development
3. Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
4. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
5. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
6. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
7. CareFusion Initiates Class I Recall of EnVe Ventilators
8. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
9. ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
10. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
11. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ALGONQUIN, Ill. , Aug. 4, 2015 /PRNewswire/ ... of dental supplies and equipment, today announced the ... of Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL ... materials used in preventive and restorative dental procedures. ... strategic expansion of our business in attractive, high-growth ...
(Date:8/4/2015)...  Eli Lilly and Company (NYSE: LLY ) ... of its intent to end its contract with the ... Asymptomatic Alzheimer,s disease (A4) study. The A4 study is ... stage of Alzheimer,s disease in older individuals who have ... scan, but do not show symptoms of memory impairment. ...
(Date:8/4/2015)... VIEW, Calif. , Aug. 4, 2015  IRIDEX ... James H. Mackaness , who had served as chief ... since 2012, has resigned his positions with the Company, ... officer position at another company. Mr. Mackaness intends to ... Company,s second quarter earnings announcement and 10-Q filing. ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2
(Date:8/4/2015)... ... August 04, 2015 , ... Statement by Paul Gionfriddo, President ... of the Mental Health Reform Act of 2015 by Senators Bill Cassidy ... reform a reality in America. , “This legislation and H.R. 2646 ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain Research ... , As corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain are ... not to say that one causes the other. Rather, there appear to be multiple ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River Casinos, the charity event ... nonprofit organization. , According to the New Foundation AZ spokesperson , the organization ... that includes a complimentary foursome for the tournament, as well as getting their company ...
(Date:8/4/2015)... Miami, FL (PRWEB) , ... August 04, 2015 ... ... engineer of patented products, announces the Assisted Dumbbell Bench Rack, a fitness invention ... in the gym. , "The Gym, Health and Fitness Clubs industry is worth ...
(Date:8/4/2015)... OH (PRWEB) , ... August 04, 2015 , ... ... that it has joined the American Association of Tissue Banks (AATB) as an ... and its mission “to honor donors, and to save and improve lives by ...
Breaking Medicine News(10 mins):Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Exsurco Medical Joins AATB as Affiliate Member 2
... newsletter deals with two pressing societal concerns the ... perspective of older minority adults. WHAT,S HOT is ... (GSA), the country,s largest interdisciplinary organization devoted to the ... by sanofi-aventis. Based on presentation highlights from GSA,s ...
... puzzle, because less visceral fat should mean less obesity-linked ... -- Blacks tend to carry around less of a ... though they suffer more from obesity-linked illness, researchers report. ... guidelines may need to be tailored to specific racial ...
... , , SAN DIEGO, Dec. 18 I AM ... an event to bring peace and wellness to children and their ... suffer from illnesses such as asthma, diabetes and cancer, as well ... stress and pain. This will be an inspiring and eye-opening event ...
... University of Vigo, Rutgers University in the United States ... developed "laser spinning", a novel method of producing glass ... bioglass nanofibres, the bioactive glass used in regenerating bone, ... possible to produce glass nanofibres of compositions that would ...
... , ... an inescapable part of modern life. According to Patt Lind-Kyle, the key to thriving (instead ... instead of allowing it to manage you. , ... Fulton, CA (PRWEB) December 18, 2009 -- Stress and worry consume many ...
... Local ... ... 2009 -- Milton & DeKruif, a Glendale - based law firm serving the needs of ... development campaign in order to raise its market visibility in front of new and existing ...
Cached Medicine News:Health News:Blacks Have Less 'Bad Fat' Than Whites 2Health News:Blacks Have Less 'Bad Fat' Than Whites 3Health News:Blacks Have Less 'Bad Fat' Than Whites 4Health News:Kids Discover Their Magic for Helping Patients and Families 2Health News:Dancing in the Eye of the Hurricane: How to Stop Running from Stress…and Start Asking It to Dance 2Health News:Dancing in the Eye of the Hurricane: How to Stop Running from Stress…and Start Asking It to Dance 3Health News:Dancing in the Eye of the Hurricane: How to Stop Running from Stress…and Start Asking It to Dance 4Health News:Milton & DeKruif Launches New Client Development Campaign 2
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Medicine Products: